Citation only
via Europe PMC
Centenarian patients with neovascular age-related macular degeneration.
Capuano V, Fragiotta S, Abadou J, Sacconi R, Miere A, Amoroso F, Souied EH, Querques G.
Retina (Philadelphia, Pa.) · 2026
Abstract
<h4>Purpose</h4>To report clinical characteristics of exudative neovascular age-related macular degeneration (AMD) in centenarian patients.<h4>Methods</h4>A retrospective, longitudinal study conducted in two retinal referral centers in Europe. Clinical characteristics of neovascular AMD patients having at last follow up at least ≥ 100 years were reviewed.<h4>Results</h4>Twenty-eight eyes from 14 patients (13 females), with a mean baseline age of 95.7 (SD 4.1) years and a mean follow-up duration of 89 months (39.9). The mean age at last follow-up was 102.4 (1.7) years. Most eyes (86%) presented type 1 macular neovascularization (MNV). At the last follow-up, best corrected visual acuity (BCVA) was stable or improved in 57% of eyes, with a mean final BCVA of 53 letters (21.8) Snellen equivalent 20/100. Eyes with better visual outcomes (>50 letters) had significantly higher baseline BCVA (p<0.001) and thicker subfoveal choroidal thickness (p=0.03). Macular hemorrhage (25%) and macular atrophy (53.6%) were associated with poorer BCVA.<h4>Conclusion</h4>Centenarian patients with neovascular AMD can maintain vision with long-term anti-VEGF therapy. These findings underscore the need for tailored management strategies for the challenges faced by centenarians with neovascular AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1097/iae.0000000000004837
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
V, C., S, F., J, A., R, S., A, M., F, A., EH, S., & G., Q. (2026). Centenarian patients with neovascular age-related macular degeneration. <em>Retina (Philadelphia, Pa.)</em>. https://doi.org/10.1097/iae.0000000000004837
Vancouver
V C, S F, J A, R S, A M, F A, et al. Centenarian patients with neovascular age-related macular degeneration. Retina (Philadelphia, Pa.). 2026. doi:10.1097/iae.0000000000004837.
BibTeX
@article{capuano2026Centen,
title = {Centenarian patients with neovascular age-related macular degeneration.},
author = {Capuano V and Fragiotta S and Abadou J and Sacconi R and Miere A and Amoroso F and Souied EH and Querques G.},
journal = {Retina (Philadelphia, Pa.)},
year = {2026},
doi = {10.1097/iae.0000000000004837},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European journal of ophthalmology 2026
Citation only
Long-term evolution of macular fibrosis in neovascular age-related macular degeneration.
Vision (Basel, Switzerland) 2026
Open access · OA
Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan.
Ophthalmologica 1999
Citation only
Natural History of Macular Subretinal Hemorrhage in Age-Related Macular Degeneration
International journal of ophthalmology 2026
Citation only
Efficacy and safety of intravitreal conbercept treat-and-extend regimens in neovascular age-related macular degeneration.
New England Journal of Medicine 2004
Open access · OA
Pegaptanib for Neovascular Age-Related Macular Degeneration
Retina 2006
Citation only